Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, No Hee | - |
dc.contributor.author | Chang, Ji-Won | - |
dc.contributor.author | Choi, June | - |
dc.contributor.author | Jung, Hak Hyun | - |
dc.contributor.author | Im, Gi Jung | - |
dc.date.accessioned | 2021-09-06T04:48:40Z | - |
dc.date.available | 2021-09-06T04:48:40Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2013-02 | - |
dc.identifier.issn | 0937-4477 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/104095 | - |
dc.description.abstract | Ras-related C3 botulinum toxin substrate 1 (RAC1) is a 21-kDa signaling G protein that functions as a pleiotropic regulator of many cellular processes including epithelial differentiation. RAC1 activates the nicotinamide adenine dinucleotide phosphate oxidase complex which promotes formation of reactive oxygen species and degradation enzymes. RAC1 has been associated with rapid epithelial differentiation and invasive properties in human cholesteatoma. This study aimed to identify the presence of RAC1 in human cholesteatoma and analyze its functional role as a regulator of proteolysis and overgrowth. Tissue samples from human cholesteatoma and normal postaural skin were obtained from patients during otologic surgery for cholesteatoma. The expression of RAC1 mRNA was quantified by real-time RT-PCR, and localization of RAC1 expression was confirmed using immunohistochemical staining. Expression of RAC1 mRNA in the epithelium of cholesteatoma was significantly elevated 2.94 fold on average, compared with normal control skin. RAC1 expression in the suprabasal and basal layer of cholesteatoma epithelium was stronger than normal control skin. Our results suggest that RAC1 can be associated with rapid epithelial differentiation and invasive properties of human cholesteatoma. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | RHO | - |
dc.subject | PROTEINS | - |
dc.subject | GTPASES | - |
dc.subject | FAMILY | - |
dc.title | Expression of Ras-related C3 botulinum toxin substrate 1 (RAC1) in human cholesteatoma | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Choi, June | - |
dc.contributor.affiliatedAuthor | Jung, Hak Hyun | - |
dc.contributor.affiliatedAuthor | Im, Gi Jung | - |
dc.identifier.doi | 10.1007/s00405-012-1966-y | - |
dc.identifier.scopusid | 2-s2.0-84878344733 | - |
dc.identifier.wosid | 000314295800008 | - |
dc.identifier.bibliographicCitation | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, v.270, no.2, pp.455 - 459 | - |
dc.relation.isPartOf | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY | - |
dc.citation.title | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY | - |
dc.citation.volume | 270 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 455 | - |
dc.citation.endPage | 459 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Otorhinolaryngology | - |
dc.relation.journalWebOfScienceCategory | Otorhinolaryngology | - |
dc.subject.keywordPlus | RHO | - |
dc.subject.keywordPlus | PROTEINS | - |
dc.subject.keywordPlus | GTPASES | - |
dc.subject.keywordPlus | FAMILY | - |
dc.subject.keywordAuthor | Ras-related C3 botulinum toxin substrate 1 protein (RAC1 protein) | - |
dc.subject.keywordAuthor | Cholesteatoma | - |
dc.subject.keywordAuthor | Reactive oxygen species | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Epithelial cells | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.